CuraSen Therapeutics, Inc.

📍 San Carlos, United States🗓 Founded 2017👥 16 employees💰 Last funded Oct 2018
Biotechnology Research🌐 curasen.com
Website LinkedIn
It’s time to think again about therapies for neurodegenerative disease. At CuraSen, we are targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN. CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population. At CuraSen, we are rethinking the therapeutic approach to treatment of neurodegenerative diseases—and advancing a concept based on restoring a key functionality to a pathway lost early in the degenerating brain. This pathway emanates from the locus coeruleus (LC), site of the earliest pathology seen in these diseases – perhaps the ‘hypocenter’ of neurodegeneration. We began clinical testing of our hypothesis in 2019 using established drugs from other therapeutic areas, which has informed our development program and helped advance our first new chemical entity, CST-2032, to the clinic in September 2020. CuraSen has assembled an impressive team, deeply experienced in the neuroscience, pharmacology and clinical development core to its approach, as well as top tier investor backing, including New Leaf Venture Partners, Longitude Capital, funds managed by Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and Pappas Capital.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CuraSen Therapeutics, Inc.?
CuraSen Therapeutics, Inc. has 2 investors on record on gritt.io, including 2 early-stage backers.
When did CuraSen Therapeutics, Inc. last raise funding?
The most recent investment in CuraSen Therapeutics, Inc. recorded on gritt.io was in October 2018.
When was CuraSen Therapeutics, Inc. founded?
CuraSen Therapeutics, Inc. was founded in 2017.
What industry is CuraSen Therapeutics, Inc. in?
CuraSen Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CuraSen Therapeutics, Inc. based?
CuraSen Therapeutics, Inc. is headquartered in San Carlos, United States.